Gemphire Therapeutics Announces Closing of Initial Public Offering

August 10, 2016

ProNAi Licenses Cancer Drug Candidate Targeting CDC7 from Carna Biosciences

May 26, 2016

Pegasus Sustainability Nabs $2M to Develop Cleanup-facilitating Tools

April 5, 2016

ProNAi Therapeutics Granted Orphan Drug Designation for PNT2258 for the Treatment of Diffuse Large B-Cell Lymphoma

March 14, 2016

OnKöl Named Edison Awards Finalist
OnKöl to Be Recognized at Edison Awards Gala on April 21 in New York

February 12, 2016

Light Guide Systems, HP Launch Revolutionary "Blended Reality" Tech Tool for Assembly and Manufacturing Operations
Local Augmented Reality Company Partners with Tech Giant to Debut Light Guide Systems Pro on the Sprout Pro by HP Immersive Computing Platform

February 4, 2016

Paul Ryznar Makes Things Easier with Lights

January 9, 2016

ProNAi Therapeutics Added to NASDAQ Biotechnology Index

December 18, 2015

LiquidCool to Launch New Technology at SC15

November 3, 2015

ProNAi Therapeutics Announces Closing of IPO and Full Exercise of the Underwriters' Option to Purchase Additional Shares

July 21, 2015

ProNAi Appoints Dr. Barbara Klencke as Chief Development Officer

June 23, 2015

Winner of the IOT / M2M Innovation World Cup 2014/15
Category: Healthcare
OnKöl by OnKöl

March 12, 2015

ProNAi Reports Significant Activity and Ongoing Durable Responses in Relapsed or Refractory Non-Hodgkin's Lymphoma with PNT2258
Updated Results from Pilot Phase II Trial of the BCL2 Targeting DNAi® Therapeutic Reported at ASH 2014

December 5, 2014

Rugged Computer Keeps Running After It’s Dropped in an Aquarium

November 4, 2014

ProNAi Therapeutics Strengthens Senior Management Team to Advance DNAi®-based Oncology Therapeutics

October 22, 2014

OnKol Wants to Help Grandma Join the Internet of Things Movement

September 10, 2014

ProNAi Therapeutics, Inc. Names New President and Chief Executive Officer

September 3, 2014

ProNAi Therapeutics Raises $59.5 Million Series D Financing
Proceeds Will Advance Clinical Studies of Its BCL2 Targeted Cancer Drug and Other Pipeline Candidates

April 21, 2014

ProNAi Therapeutics Secures $12 Million Series C Financing to Expand Phase II Cancer Studies for PNT2258, a Novel BCL2 Inhibitor, in Defined Lymphoma Patients

January 13, 2014

LiquidCool Solutions Receives the 2013 North American Frost & Sullivan Customer Value Enhancement Award in Data Center Cooling

December 17, 2013

LiquidCool Solutions and Dedicated Computing Form Strategic Alliance to Develop Liquid Cooled Technical Computing Solutions

September 5, 2013

Great Lakes Pharmaceuticals, Inc. Announces Initiation of Clinical Trial of the Catheter Lock Solution, B-Lock™

July 26, 2012

CytoPherx Raises $34 Million to Move Into U.S. Clinical Trials
Early Stage Partners, Onset Ventures and Capital Midwest Fund Co-Lead Funding for Company Focused on Addressing Acute Kidney Injury

January 4, 2012

Sun Cofounder Evangelizes Liquid Blade Server

May 4, 2011

Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S.

April 23, 2010